BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16619374)

  • 1. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer.
    Kormosh N; Laktionov K; Antoshechkina M
    Phytother Res; 2006 May; 20(5):424-5. PubMed ID: 16619374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the plant extract complex "AdMax" on global gene expression levels in cultured human fibroblasts.
    Antoshechkin A; Olalde J; Antoshechkina M; Briuzgin V; Platinskiy L
    J Diet Suppl; 2008; 5(3):293-304. PubMed ID: 22432464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
    Ferrari S; Rovati B; Cucca L; Scarabelli C; Presti M; Beccaria C; Collovà E; Porta C; Danova M
    Oncol Rep; 2002; 9(5):1107-13. PubMed ID: 12168081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of humoral activity of Eleutherococcus senticosus.
    Drozd J; Sawicka T; Prosińska J
    Acta Pol Pharm; 2002; 59(5):395-401. PubMed ID: 12602802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
    Panossian A; Wagner H
    Phytother Res; 2005 Oct; 19(10):819-38. PubMed ID: 16261511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions.
    Aslanyan G; Amroyan E; Gabrielyan E; Nylander M; Wikman G; Panossian A
    Phytomedicine; 2010 Jun; 17(7):494-9. PubMed ID: 20374974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of molecular chaperons Hsp72 and neuropeptide Y as characteristic markers of adaptogenic activity of plant extracts.
    Asea A; Kaur P; Panossian A; Wikman KG
    Phytomedicine; 2013 Nov; 20(14):1323-9. PubMed ID: 23920279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of Eleuterococcus senticosus on cellular and humoral immunological response of mice.
    Rogala E; Skopińska-Rózewska E; Sawicka T; Sommer E; Prosińska J; Drozd J
    Pol J Vet Sci; 2003; 6(3 Suppl):37-9. PubMed ID: 14509359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effects of several herbal extracts on avian peripheral blood cell immune responses.
    Dorhoi A; Dobrean V; Zăhan M; Virag P
    Phytother Res; 2006 May; 20(5):352-8. PubMed ID: 16619362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.
    Mallmann P; Krebs D
    Methods Find Exp Clin Pharmacol; 1990 Jun; 12(5):333-40. PubMed ID: 2232966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow-cytometric studies with eleutherococcus senticosus extract as an immunomodulatory agent.
    Bohn B; Nebe CT; Birr C
    Arzneimittelforschung; 1987 Oct; 37(10):1193-6. PubMed ID: 2963645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptogens in chemobrain (Part III): Antitoxic effects of plant extracts towards cancer chemotherapy-induced toxicity - transcriptome-wide microarray analysis of neuroglia cells.
    Seo EJ; Klauck SM; Efferth T; Panossian A
    Phytomedicine; 2019 Mar; 56():246-260. PubMed ID: 30668345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on prolactin secretion of Echinacea purpurea, hypericum perforatum and Eleutherococcus senticosus.
    Di Carlo G; Pacilio M; Capasso R; Di Carlo R
    Phytomedicine; 2005 Sep; 12(9):644-7. PubMed ID: 16194051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of adaptogens on ultraweak biophoton emission: a pilot-experiment.
    Schutgens FW; Neogi P; van Wijk EP; van Wijk R; Wikman G; Wiegant FA
    Phytother Res; 2009 Aug; 23(8):1103-8. PubMed ID: 19170145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral systemic and mucosal immune responses stimulated in volunteers by an oral polybacterial immunomodulator "Dentavax".
    Petrunov B; Marinova S; Markova R; Nenkov P; Nikolaeva S; Nikolova M; Taskov H; Cvetanov J
    Int Immunopharmacol; 2006 Jul; 6(7):1181-93. PubMed ID: 16714223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.
    Vallerskog T; Gunnarsson I; Widhe M; Risselada A; Klareskog L; van Vollenhoven R; Malmström V; Trollmo C
    Clin Immunol; 2007 Jan; 122(1):62-74. PubMed ID: 17046329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconstructing an adaptogen: Eleutherococcus senticosus.
    Bleakney TL
    Holist Nurs Pract; 2008; 22(4):220-4. PubMed ID: 18607235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.
    Kosmidis S; Baka M; Bouhoutsou D; Doganis D; Kallergi C; Douladiris N; Pourtsidis A; Varvoutsi M; Saxoni-Papageorgiou F; Vasilatou-Kosmidis H
    Pediatr Blood Cancer; 2008 Mar; 50(3):528-32. PubMed ID: 17853465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.